Dangerous Products – Celebrex

Celebrex (celecoxib or original) is a controversial drug for rheumatoid arthritis, osteoarthritis, acute pain, migraine and acute pain and menstrual pain. Celebrex is also used for the number of intestinal polyps in patients with an increase of rare genetic disorder called familial adenomatous polyposis (FAP), designed to reduce cancer untreated. This medicine is an anti-inflammatory drugs (in particular, a "COX-2) and is prescribed to relieve pain and swelling.

Celebrex was associated with an increased risk of heart attack or stroke in patients who took the drug had a long association known. In addition, patients taking the drug over a long period there bleed ulcers to liver damage, leading to kidney failure kidney failure and fluid retention. It is manufactured by Pfizer Inc. and has been introduced in Canada in 1999. The drug has attracted attention as Vioxx was withdrawn appropriate medical in 2004. This event led to a lot of action against Celebrex, is still medicine has experienced a brief rise in sales. During the study, Vioxx or Celebrex, said that similar chemical and can cause similar problems, leading to a decline in sales of Celebrex. This is in 2006; the situation is stable and advertising Celebrex Pfitzer again. The protests are allowed to publicize the cause of consumer interest groups, but when Celebrex State Food and Drugs. In 2008, Celebrex and Extra more consistent Pfitzer (a similar drug, was recalled in April 2005) lamentations. Vioxx and Bextra Despite strong prohibitions on all available studies, there is no support to the conclusion that Celebrex, the risk of a heart attack and stroke increases.

Celebrex in Canada has a strong opposition, which led to a class action in 2005 in British Columbia. The action by laws Poyner Baxter as well as a lawsuit against Vioxx completed. The withdrawal of Vioxx from the market due to sufficient reasons, a similar suit against a drug similar file - Celebrex. The company said that the medicine the risk of serious adverse cardiovascular events including heart attack, stroke, angina, atrial fibrillation, bradycardia, hematoma, irregular heartbeat, palpitation, premature ventricular contraction, tachycardia, congestive venous disease, stroke, heart failure, increased absenteeism, deep vein thrombosis, pulmonary embolism, transient ischemic attack, unstable angina, and occlusion. As in many trials involving hazardous Pfitzer Poyner Baxter has argued that the negative effects of the drug, however, continue to sell and market. The current process is not yet clear, nor Celebrex continue to be sold, but with stronger warnings.

Today, if you or your children against the effects of Celebrex on the file, you still suffer from conflict and you will be supported by many organizations, anti-Celebrex. The most important things in this process will gather medical information that proves that the person taking Celebrex and the person, the effects caused by it and looking for a good lawyer, of course.